✨ Your Portfolio is fetched and updated from zerodha.
Small NBFC

Piramal Enterprises Ltd.

PEL

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹25,927 Cr.
P/E
44.68

Piramal Enterprises Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
25,927 Cr
PE
PE
44.68
Prom Holding
Prom Holding
46.16 %
ROE (%)
ROE (%)
1.79
ROCE (%)
ROCE (%)
8.43
Div Yield (%)
Div Yield (%)
0.96
Sales
Sales
10,232 Cr
OPM (%)
OPM (%)
53.40 %
Debt to Equity
Debt to Equity
2.43
View more
Edit Ratio's

About

Piramal Enterprises Limited is classified as a Non-Banking Finance Company - Middle Layer enga… Read more
Low
848
52W Range
High
1355
  • Piramal Enterprises
  • Manappuram Finance
  • CreditAccess Grameen
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Borrowings Break-Up

Borrowing Break-Up - Investor Type

AUM Break-Up - NBFC

Verticals - Retail

Verticals - Wholesale

Operational Metrics

    locked
    Select a Metric

    Peer Comparison

    Brands

    Lacto Calamine
    Saridon
    i-pill

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Bharat Dynamics Ltd.
    • Iris Business Services Ltd.
    • GP Petroleums Ltd.

    Customers

    • Astrazeneca Pharma India Ltd.
    • Bayer CropScience Ltd.
    • Procter & Gamble Health Ltd.
    • Novartis India Ltd.
    • Pfizer Ltd.

    FAQs on Piramal Enterprises Ltd. Business

    Piramal Enterprises Limited is classified as a Non-Banking Finance Company - Middle Layer and provides comprehensive financing solutions to companies in various sectors including real estate and non-real estate sectors.

    Piramal Enterprises major competitors are Manappuram Finance, CreditAccess Grameen, Capri Global Capital, Cholamandalam Fin., Poonawalla Fincorp, Five Star Business, IFCI.
    Market Cap of Piramal Enterprises is ₹25,927 Crs.
    While the median market cap of its peers are ₹21,174 Crs.

    Piramal Enterprises seems to be less financially stable compared to its competitors.
    Altman Z score of Piramal Enterprises is 0.77 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release May Jul Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec Mar Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Dec Mar Jun Sep Dec Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Dec Dec
    Investor Presentation Mar May Jun Jul Aug Sep Mar Jun Sep Dec Mar Jun Aug Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Dec Mar Jun Sep Dec Jun Sep
    Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec Sep Dec Jun Jun Sep Dec Sep Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Piramal Enterprises Ltd.
    One Upcoming Special Situation Opportunity - SOIC
    View the discussion on ValuePickr
    Piramal Enterprises and upcoming special situation - The Average Trader
    Special Situation - Demerger Of Piraml Enterprise & Piramal Pharma - SOIC
    Transformation of Piramal group post 2018 NBFC crisis - Business Today
    NBFC
    Buy Now Pay Later - Capital Mind
    Deep Dive into NBFC Business - Omkara Capital
    Asset Liability Mismatch: Why do NBFCs & Banks knowingly create it? - Dr Vijay Malik
    NBFC & Banks| How to find Multibaggers in this sector! - SOIC
    Masterclass on NBFC sector by Mr Umesh Agarwal - Finnacle
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material